PHVS
Pharvaris Nv
NASDAQ · Pharmaceuticals
$26.42
+1.28 (+5.09%)
Open$25.50
Previous Close$25.14
Day High$26.97
Day Low$25.39
52W High$29.80
52W Low$11.51
Volume—
Avg Volume143.2K
Market Cap1.69B
P/E Ratio—
EPS$-2.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
-15.2% upside
Current
$26.42
$26.42
Target
$22.40
$22.40
$12.72
$22.40 avg
$29.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 601.07M | 622.81M | 541.11M |
| Net Income | 107.25M | 120.49M | 94.92M |
| Profit Margin | 17.8% | 19.4% | 17.5% |
| EBITDA | 198.86M | 206.18M | 175.68M |
| Free Cash Flow | 71.76M | 51.92M | 65.95M |
| Rev Growth | +10.0% | +14.9% | +24.5% |
| Debt/Equity | 0.21 | 0.20 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |